JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hemby, S. E.
Right arrow Articles by Dworkin, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hemby, S. E.
Right arrow Articles by Dworkin, S. I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*COCAINE
*HEROIN
*NALTREXONE

The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats [published erratum appears in J Pharmacol Exp Ther 1996 Oct;279(1):442]

SE Hemby, JE Smith and SI Dworkin

Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.

In the first experiment, responding was maintained for food under a fixed ratio (FR) 10 with a 6-min timeout reinforcement schedule. Eticlopride (0.1-1.0 mg/kg i.p.) dose-dependently decreased the number of food pellets obtained, whereas naltrexone (3-30 mg/kg i.p.) did not significantly alter responding. In the second experiment, intravenous self-administration of cocaine (vehicle, 125, 250 and 500 micrograms/infusion), heroin (vehicle, 5.4, 9 and 18 micrograms/infusion) and cocaine/heroin combinations were maintained under a FR10 reinforcement schedule. Cocaine/heroin combinations included the aforementioned cocaine doses combined with 5.4 micrograms/infusion heroin (CH5.4) or 18 micrograms/infusion heroin (CH18). Cocaine/heroin combinations dose-dependently decreased the number of infusions compared with cocaine alone. Eticlopride (0.03-0.3 mg/kg i.p.) decreased self-administration of 125 micrograms/infusion cocaine and increased self-administration of 500 micrograms/infusion cocaine. Self-administration of 250 micrograms/infusion cocaine was increased after 0.03 and 0.1 mg/kg and decreased after 0.3 mg/kg eticlopride. Eticlopride decreased heroin self-administration, an effect which may be attributable to its rate-decreasing effects. Eticlopride partially reversed the downward shift of the CH5.4 group but did not reverse the effect in the CH18 group. Naltrexone (1.0-10.0 mg/kg i.p.) decreased self-administration of 5.4 micrograms/infusion heroin and increased self-administration of 18 micrograms/infusion heroin. Self-administration of 9 micrograms/infusion heroin was increased by 1.0 mg/kg, not affected by 3.0 mg/kg and decreased by 10.0 mg/kg naltrexone. For the CH5.4 and CH18 groups, naltrexone dose- dependently shifted the dose-effect curves toward the cocaine dose- effect curve. Therefore, self-administration of cocaine/heroine combinations can be maintained in the rat and downward shifts in the cocaine dose-effect curve after combination with heroin are mediated through a naltrexone-sensitive mechanism.

Volume 277, Issue 3, pp. 1247-1258, 06/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. K. Rowlett, D. M. Platt, W.-D. Yao, and R. D. Spealman
Modulation of Heroin and Cocaine Self-Administration by Dopamine D1- and D2-Like Receptor Agonists in Rhesus Monkeys
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1135 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. N. Haile and T. A. Kosten
Differential Effects of D1- and D2-Like Compounds on Cocaine Self-Administration in Lewis and Fischer 344 Inbred Rats
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 509 - 518.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. K. Rowlett, K. M. Wilcox, and W. L. Woolverton
Self-Administration of Cocaine-Heroin Combinations by Rhesus Monkeys: Antagonism by Naltrexone
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 61 - 69.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. S. Negus, M. B. Gatch, and N. K. Mello
Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
N. K. Mello and S. S. Negus
The Effects of Buprenorphine on Self-administration of Cocaine and Heroin "Speedball" Combinations and Heroin Alone by Rhesus Monkeys
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 444 - 456.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.